Skip to main content
. Author manuscript; available in PMC: 2020 May 31.
Published in final edited form as: Pharm Res. 2019 May 31;36(8):113. doi: 10.1007/s11095-019-2645-0

Table III.

Median parameter values for compounds with lower vs. higher CV values with (n)

CV fub fup # Rot Bonds HBA & HBD LogD CLint, in vivo LogP PSA HBA VDSS CLint, in vivo MRT fuhep MW # Aromatic Rings HBD
<50% 0.067(17) 0.053(17) 4.0(17) 6.0(17) 2.2(17) 5.4(17) 2.5(17) 57(17) 4.0(17) 1.2(17) 96(17) 3.3 (17) 0.88(17) 314(17) 2.0(17) 1.0(17)
>50% 0.16(16) 0.1 1 (16) 2.5(16) 4.5(16) 1.7(16) 6.8(16) 2.9(16) 50(16) 3.5(16) l.l (15) 103(16) 3.5(15) 0.91 (16) 304(16) 2.0(16) 1.0(16)